In this study, we examined the effect of PRC2 inhibition on AKI and mechanisms involved by employing EED226, a highly selective PRC2 inhibitor that directly binds to the H3K27me3 binding pocket of EED, resulting in loss of PRC2 activity, in a murine model of cisplatin‐induced AKI. The gene discussed is EED; the disease is acute kidney injury.